Hinge Health, Inc.

NYSE:HNGE Stock Report

Market Cap: US$7.1b

Hinge Health Future Growth

Future criteria checks 6/6

Hinge Health is forecast to grow earnings and revenue by 27.1% and 20% per annum respectively. EPS is expected to grow by 23.4% per annum. Return on equity is forecast to be 20.2% in 3 years.

Key information

27.1%

Earnings growth rate

23.35%

EPS growth rate

Healthcare earnings growth17.4%
Revenue growth rate20.0%
Future return on equity20.22%
Analyst coverage

Good

Last updated13 Aug 2026

Recent future growth updates

Recent updates

Narrative Update • Aug 07

HNGE: Multi Condition Platform Expansion And Buybacks Will Support Long Term Upside

Analysts have lifted their implied fair value estimate for Hinge Health from about $111 to roughly $137, citing a higher average price target across recent research that points to Q2 outperformance, new product traction, acquisitions, and an updated long term model that assumes slightly higher discount rates, a lower profit margin profile, and a richer future P/E multiple offset by moderated revenue growth expectations. Analyst Commentary Recent Street research on Hinge Health points to increasingly constructive sentiment, with a series of higher price targets grouped around updated models, stronger than expected Q2 commentary, and new product launches such as Migraine Care, HingeSelect, and the planned expansion into GI health.
Narrative Update • Jul 24

HNGE: Product Expansion And Guidance Updates Will Drive Multi Year Upside

Hinge Health's analyst price target has been reset higher, with fair value moving from $64.29 to $90.87 as analysts factor in updated models around product expansion, member growth signals, and recent guidance updates across the digital health sector. Analyst Commentary Recent research updates on Hinge Health point to a cluster of higher price targets and generally positive views on the company’s expansion into new offerings, while also flagging execution risks as expectations rise into upcoming earnings events.
Seeking Alpha • Jul 21

Hinge Health: My Hidden Gem Pick Has Performed Well, But It's Time For A Cool-Off (Downgrade)

Summary Hinge Health has delivered an impressive near-50% rally in just over six weeks. I initially highlighted HNGE’s 85% gross margins and innovative migraine care program as key growth drivers. The growth story remains compelling, but after the rapid appreciation, I am downgrading HNGE from 'strong buy' to 'buy.' This adjustment reflects prudent risk management following a significant short-term run-up, not a loss of conviction in HNGE’s long-term prospects. Read the full article on Seeking Alpha
Narrative Update • Jul 10

HNGE: Raised Guidance And New Programs Will Support Stronger Long Term Margins

Analysts have lifted the Hinge Health fair value estimate from $72.00 to about $110.97, citing updated assumptions around multi-year growth, stronger profit margins, and a lower future P/E multiple following recent Investor and Analyst Day updates. Analyst Commentary Recent Street research on Hinge Health points to a broadly constructive view, with multiple bullish analysts revising price targets higher after the company’s Investor and Analyst events and product updates.
Narrative Update • Jun 26

HNGE: Multi Product Expansion Could Struggle To Justify Rich Future Expectations

The analyst fair value estimate for Hinge Health has been revised from $43.40 to $65.00, reflecting higher modeled revenue growth and Street research highlighting confidence in multi-year growth potential, new products such as Surgery and Migraine Care, and continued momentum following recent Investor and Movement conferences. Analyst Commentary Recent Street research on Hinge Health has centered on the company’s expanding product set, revised guidance, and evolving long term targets.
New Narrative • Mar 08

Expanding Digital MSK Reach And AI Care Tools Will Transform Long-Term Earnings Potential

Catalysts About Hinge Health Hinge Health provides a technology driven musculoskeletal care platform that combines digital physical therapy, connected devices and in person providers for employers and health plans. What are the underlying business or industry changes driving this perspective?
New Narrative • Feb 22

AI Efficiency And Engagement Based Pricing Will Shape Musculoskeletal Care Outlook

Catalysts About Hinge Health Hinge Health provides technology enabled care programs focused on musculoskeletal conditions, combining digital physical therapy, connected hardware and in person provider networks. What are the underlying business or industry changes driving this perspective?

Earnings and Revenue Growth Forecasts

NYSE:HNGE - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20281,3262814755368
12/31/20271,08721135640015
12/31/202685916229931015
6/30/2026720107284291N/A
3/31/2026646-511203210N/A
12/31/2025588-424165171N/A
9/30/2025534-429141146N/A
6/30/2025481-4278792N/A
3/31/20254321368387N/A
12/31/2024390-124549N/A
12/31/2023293-108-69-64N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: HNGE's forecast earnings growth (27.1% per year) is above the savings rate (3.7%).

Earnings vs Market: HNGE's earnings (27.1% per year) are forecast to grow faster than the US market (17.2% per year).

High Growth Earnings: HNGE's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: HNGE's revenue (20% per year) is forecast to grow faster than the US market (13% per year).

High Growth Revenue: HNGE's revenue (20% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: HNGE's Return on Equity is forecast to be high in 3 years time (20.2%)

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/08/14 11:40
End of Day Share Price 2026/08/14 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Hinge Health, Inc. is covered by 17 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Vikram KesavabhotlaBaird
Saket KaliaBarclays
Bradley SillsBofA Global Research